Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
IVVD compared with MNPR: revenue, margins and what each company keeps, and the suppliers and customers both name
IVVD
Invivyd, Inc.
Change
Mkt cap
Revenue
Revenue
MNPR
Monopar Therapeutics
Change
Mkt cap
Revenue
Revenue
vs
Compare
IVVD
Invivyd, Inc.
vs
MNPR
Monopar Therapeutics
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
IVVD
Invivyd, Inc.
Change
0.59
▼
−2.76%
· post 0.59
Mkt cap
$171.5M
Revenue
$14M
Q2 FY26
Revenue
$53M
FY25
MNPR
Monopar Therapeutics
Change
69.99
▼
−2.66%
· post 69.99
Closed
Oct 30 '26
Mkt cap
$472.0M
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
IVVD
Invivyd, Inc.
vs
MNPR
Monopar Therapeutics
0.59
▼
−2.76%
post 0.59
Price
69.99
▼
−2.66%
post 69.99
$171.5M
Mkt cap
$472.0M
Q2 FY26
$14M
Revenue
—
FY25
$53M
Revenue
—
Change
Change
IVVD
0.59
▼
−2.76%
vs
MNPR
69.99
▼
−2.66%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
IVVD, solid
MNPR, dashed
Supply-chain overlap
Revenue flow
IVVD: latest quarter is a loss; flow not drawable. MNPR: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only IVVD
9
—
Undisclosed specialty distributor customer
unlisted
customer
—
Adimab
unlisted
supplier
—
WuXi Biologics
unlisted
supplier
—
WuXi Biologics (Hong Kong)
unlisted
supplier
5 more · IVVD chain
›
Shared
0
No shared counterparties.
Only MNPR
2
AZN
AstraZeneca
supplier
—
NorthStar
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR